Structure |
Chemical Name |
CAS |
MF |
|
SalMeterol IMpurity D |
|
C25H37NO4 |
|
SulbactaM IMpurity A |
|
|
|
Tigecycline Metabolite M6 (9-AniMoMinocycline) |
149934-19-0 |
C23H28N4O7 |
|
VerapaMil IMpurity G |
|
C27H38N2O4 |
|
EthanediaMide iMpurity D |
480452-36-6 |
C21H30ClN5O5 |
|
N-(4-(2-Methyl-5,6-dihydro-4H-benzo[b]oxazolo[5,4-d]azepine-6-carbonyl)phenyl)-[1,1'-biphenyl]-2-carboxaMide |
168626-93-5 |
C32H25N3O3 |
|
Methyl (4-Methylpiperidin-3-yl)carbaMate |
1204176-45-3 |
C8H16N2O2 |
|
(R)-3-(4-(5-broMo-2-chlorobenzyl)phenoxy)tetrahydrofuran |
915095-90-8 |
C17H16BrClO2 |
|
(2S,3R,4S,5S,6R)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)Methyl)-4-Methylphenyl)-tetrahydro-6-(hydroxyMethyl)-2-Methoxy-2H-pyran-3,4,5-triol |
1358581-37-9 |
C25H27FO6S |
|
Levocarnitine iMpurity |
6490-20-6 |
C7H17ClN2O2 |
|
3-Hydroxy-4-Methyl-2(5H)-thiophenone |
34876-35-2 |
C5H6O2S |
|
(1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-3,7-diMethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl Ester (2Z)-2-Methyl-2-butenoic Acid |
1048973-04-1 |
C24H34O5 |
|
(6α)-17,21-Dihydroxy-6-Methylpregna-1,4,9(11)-triene-3,20-dione |
93269-35-3 |
C22H28O4 |
|
[N(Z)]-N-(3,5-ジメチル-2(3H)-チアゾリリデン)-4-ヒドロキシ-2-メチル-2H-1,2-ベンゾチアジン-3-カルボキサミド1,1-ジオキシド |
1262333-25-4 |
C15H15N3O4S2 |
|
1,2-ビス[2-(4-ジベンゾ[B,F][1,4]チアゼピン-11-イル-1-ピペラジニル)エトキシ]エタン |
1371638-05-9 |
C40H44N6O2S2 |
|
2-[3-カルボキシ-4-(2-メチルプロポキシ)フェニル]-4-メチル-5-チアゾールカルボン酸 |
1239233-87-4 |
C16H17NO5S |
|
4-(2-メチルプロピル)ベンゼンエタノール |
36039-35-7 |
C12H18O |
|
Dasatinib DiMeric IMpurity |
910297-61-9 |
C36H34Cl2N12O2S2 |
|
Decarboxy Fexofenadine |
185066-37-9 |
C31H39NO2 |
|
Methotrexate α-Methyl Ester |
66147-29-3 |
C21H24N8O5 |
|
17- Phenyl Trinor Prostaglandin F2α Methyl Amide |
155206-01-2 |
C24H35NO4 |
|
ベンダマスチンデスクロロ二量體不純物 |
1391052-61-1 |
C32H44N6O7 |
|
(2R,3R)-3-アミノ-2-ヒドロキシ-3-フェニルプロパン酸メチル |
157722-44-6 |
C10H13NO3 |
|
Benzenebutanoicacid,b-aMino-2,4,5-trifluoro-,Methylester,(bR)- |
881995-69-3 |
C11H12F3NO2 |
|
Bisoprolol IMpurity |
2226263-67-6 |
C18H31NO4 |
|
Decitabine iMpurity 5 |
|
|
|
N-(3-ブロモフェニル)-6,7-ビス(2-メトキシエトキシ)-4-キナゾリンアミン |
328528-74-1 |
C20H22BrN3O4 |
|
LevetiracetaM IMpurity 3 |
1543353-92-9 |
C8H15NO4 |
|
(3R,4R,5R)-4-(1-エチルプロポキシ)-3-ヒドロキシ-5-[(メチルスルホニル)オキシ]-1-シクロヘキセン-1-カルボン酸エチルエステル |
204254-94-4 |
C15H26O7S |
|
9,11-Anhydrobudesonide |
313474-58-7 |
C25H32O5 |
|
iperazineacetic acid, 4-[(4- chlorophenyl)phenylMethyl]- |
113740-61-7 |
C19H21ClN2O2 |
|
(2R,3R,4R,5R)-5-(4-benzaMido-2-oxopyriMidin-1(2H)-yl)-2-((benzoyloxy)Methyl)-4-chloro-4-Methyltetrahydrofuran-3-yl benzoate |
1496551-70-2 |
C31H26ClN3O7 |
|
1-((2R,3S,4R,5R)-3,4-dihydroxy-5-(hydroxyMethyl)-3-Methyltetrahydrofuran-2-yl)pyriMidine-2,4(1H,3H)-dione |
114262-49-6 |
C10H14N2O6 |
|
4-(4-(3-(4-chloro-3-(trifluoroMethyl)phenyl)ureido)-3-fluorophenoxy)-2-(MethylcarbaMoyl)pyridine 1-oxide |
835621-11-9 |
C21H15ClF4N4O4 |
|
1-[1-(4-Chlorophenyl)cyclobutyl]-3-methylbutan-1-one |
186521-85-7 |
C15H19ClO |
|
NSC 351869 |
31350-27-3 |
C14H14N2O4 |
|
N-(1-エチルピロリジン-2-イルメチル)-4-アミノ-5-ヨード-2-メトキシベンズアミド |
176849-91-5 |
C15H22IN3O2 |
|
N,N'-Vis[2-(3,4-dimethoxyphenyl)ethyl]-N,N'-dimethyl-1,3-propanediamine dihydrochloride |
63434-11-7 |
C25H39ClN2O4 |
|
(3R,4S,5S,6R)-2-[4-chloro-3-[[4-[(3S)-oxolan-3-yl]oxyphenyl]methyl]phenyl]-6-(hydroxymethyl)-2-methoxyoxane-3,4,5-triol |
915095-96-4 |
C24H29ClO8 |
|
Doxorubicin Imp B HBr salt |
148218-14-8 |
C29H35Br2NO11 |
|
(R)-2-(Boc-aMino)-2-phenylethyl 4-Methylbenzenesulfonate |
126610-77-3 |
C20H25NO5S |
|
(2R,3R,4R,5S)-5-(4-chloro-3-(4-((S)-tetrahydrofuran-3-yloxy)benzyl)phenyl)-2-(2-hydroxyethyl)tetrahydrofuran-2,3,4-triol |
|
C23H27ClO7 |
|
Pyrido[2,3-d]pyriMidin-7(8H)-one, 8-cyclopentyl-5-Methyl-2-[[5-(1-piperazinyl)-2-pyridinyl]aMino]-, hydrochloride (1:) |
571189-66-7 |
C22H28ClN7O |
|
Olaparib iMpurity |
|
|
|
(2S,3R,4R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-5-((S)-1,2-dihydroxyethyl)tetrahydrofuran-3,4-diol |
|
C21H25ClO6 |
|
(R)-Methyl 3-aMino-4-(2,4,5-trifluorophenyl) butanoate .(R)-2-hydroxy-2-phenylacetate |
1253055-94-5 |
C19H20F3NO5 |
|
Olaparib iMpurity A |
|
|
|
(1S,2S,3R,5S)-3-(7-chloro-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyriMidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
|
C14H20ClN5O4S |
|
Posaconazole iMpurity 5 |
|
|
|
Topiroxostat Impurity 5 |
1199273-82-9 |
C14H7N7 |
|
N-Ethoxycarbonyl Ciprofloxacin |
93594-29-7 |
C20H22FN3O5 |
|
Norepinephrine Tartrate Impurity G |
13062-58-3 |
C22H21NO3 |
|
Vortioxetine Impurity 1 |
1293489-71-0 |
C17H20N2S |
|
4-bromo-2-nitropyridine |
909712-10-3 |
C5H3BrN2O2 |
|
1,3-Bis(1H-1,2,4-triazol-1-yl)-2-propanone |
98414-56-3 |
C7H8N6O |
|
2-[[(3aR,4S,6R,6aS)-6-(7-azanyl-5-propylsulfanyl-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,2-dimethyl-4,5,6,6a-tetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl]oxy]ethanol |
1354945-69-9 |
C17H26N6O4S |
|
Vonoprazan Impurity E |
|
|
|
ジサリチルイミド |
1972-71-0 |
C14H11NO4 |
|
Atomoxetine impurity D |
1643684-02-9 |
C17H21NO |
|
Diltiazem impurity |
115992-91-1 |
C17H18N2O3S |
|
Raloxifene EP IMpurity |
1700655-64-6 |
C13H15ClN2O2S |
|
Parecoxib Impurity M |
|
|
|
Cycloocta[b]pyridine, 2-(4-ethyl-1-piperazinyl)-4-[4-(4-ethyl-1-piperazinyl)phenyl]-5,6,7,8,9,10-hexahydro- |
1648791-23-4 |
C29H43N5 |
|
Linagliptin Impurity O |
|
|
|
Linagliptin Impurity T |
|
|
|
(R)-2-((6-(3-aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)-4-fluorobenzamide |
|
C18H22FN5O3 |
|
Etoricoxib Impurity 16 |
|
|
|
Ibrutinib Impurity 2 |
|
|
|
Mirabegron Impurity 14 |
|
|
|
Vonoprazan Impurity 1 |
881732-90-7 |
C17H17N3O2S |
|
Atenolol EP Impurity |
|
C14H22N2O3 |
|
Cinacalcet Impurity 20 |
|
|
|
Dapagliflozin Impurity 11 |
|
|
|
Dasatinib Impurity C |
|
|
|
Etoricoxib impurity Q |
292067-97-1 |
C18H15ClN2S |
|
Flucloxacillin Impurity |
|
|
|
Fluorometholone Impurity |
2796-99-8 |
C23H31FO7S |
|
Verapamil Impurity |
1551304-28-9 |
C12H19NO2 |
|
Clopidogrel impurity reference substance |
|
C15H14ClNO2S |
|
Vildagliptin Impurity |
|
|
|
Dihydroxyoxaliplatin(Oxaliplatin Impurity Ⅲ) |
|
|
|
cefditoren E-isomer(C=C) |
|
|
|
Mixture of Lamivudine Impurity Ⅳ and Impurity Ⅴ |
|
|
|
2-Ethoxybenzimidohydrazide |
889943-46-8 |
C9H13N3O |
|
(E)-2-(6-(methoxycarbonyl)-2-oxoindolin-3-ylidene)-2-phenylacetic acid |
|
C18H13NO5 |
|
8-Epi-cyanocobalamin |
41325-63-7 |
C63H88CoN14O14P |
|
Lamivudine Impurity 2 |
200396-21-0 |
C18H27N3O4S |
|
Lamivudine Impurity 1 |
1235712-40-9 |
C8H11N3O4S |
|
Moxifloxacin Related Impurity 3 |
|
|
|
Bisoprolol EP Impurity Q |
1346604-00-9 |
C16H27NO4 |
|
Levofloxacin N-Oxide |
117678-37-2 |
C18H20FN3O5 |
|
Oseltamivir EP Impurity A |
1391047-93-0 |
C14H24N2O4 |
|
Quetiapine EP Impurity N |
1800291-86-4 |
C29H41N5O3S |
|
Ceftazidime Impurity |
|
|
|
Chlorhexidine Digluconate Impurity N |
152504-10-4 |
C15H25ClN8 |
|
チオ酢酸S-アゼチジン-3-イルエステル |
886615-18-5 |
C5H9NOS |
|
Olaparib Impurity C |
|
|
|
Olaparib Impurity F |
|
|
|
Dapoxetine Impurity 4 |
|
|
|
Glycopyrrolate impurity 3 |
|
|